A new biopharmaceutical company has formed after acquiring late-stage clinical drug assets from a slumping public company.

Preview this article 1 min Investor FOMO and the focus on crowning AI winners is widening the funding gap in startup land. 40 ...

Kemi Badenoch has called for Axel Rudakubana's parents to be deported if they don't face criminal action after a public ...

A recent exchange between a state lawmaker and a local official is raising questions about the free speech rights of elected ...

Key voices from boxing weigh in on the big questions surrounding heavyweight Tyson Fury's latest comeback.

As Vermont begins rolling out Act 181, a major overhaul of its land-use law, a key question is emerging: Will the new system ...

Last fall, I visited a physiotherapist. There was a sharp pain in my shoulder and it was difficult to move my neck. I ...

"if you show'd this to someone in 2015 I think they'd just spontaneously combust" ...

SIMA has submitted a proposed implementation timeline to both the Department of Finance and the CRA based on members’ input ...

A federal judge blocked an Indiana law that banned the use of college-issued student identification cards for voting, ruling that it imposed unconstitutional burdens on students and young voters in ...

Intelligence officials and industry are weighing how Claude Mythos Preview could reshape hacking and cyberdefense. The ...

Pichai's "agent manager" quote made headlines. The rest of the interview reveals a timeline, infrastructure constraints, and ...